Grants per year
- 1 - 25 out of 37 results
Search results
-
Finished
Lung delivery of novel ACE2 proteins for COVID-19
Batlle, D. (PD/PI) & Wysocki, J. (Co-Investigator)
Angiotensin Therapeutics, Inc., National Heart, Lung, and Blood Institute
9/1/22 → 2/29/24
Project: Research project
-
Novel Short ACE2 variant for Delayed Graft Function
Batlle, D. (PD/PI), Ansari, M. J. I. (Co-Investigator), Wysocki, J. (Co-Investigator) & Zhang, Z. J. (Co-Investigator)
National Institute of Allergy and Infectious Diseases
11/1/21 → 10/31/24
Project: Research project
-
NCR-19-2039- Ammonium excretion in ZS-9 treated mice with CKD
Batlle, D. (PD/PI) & Wysocki, J. (Co-Investigator)
AstraZeneca Pharmaceuticals LP
5/26/20 → 10/31/22
Project: Research project
-
The Role of MicroRNAs in Corneal Epithelial Homeostasis
Lavker, R. M. (PD/PI), Batlle, D. (Co-PD/PI), Peng, H. (Co-PD/PI) & Thaxton, C. S. (Co-PD/PI)
7/1/19 → 7/31/24
Project: Research project
-
PERL: A multicenter clinical trial of allopurinol to prevent GFR loss in T1D
Molitch, M. E. (PD/PI), Batlle, D. (Co-Investigator) & Wallia, A. (Co-Investigator)
Joslin Diabetes Center, Inc., National Institute of Diabetes and Digestive and Kidney Diseases
9/15/17 → 6/30/19
Project: Research project
-
Prot #16244: A Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multicenter, Event-Driven Phase III Study to Investigate the Efficacy and Safety of Finerenone, in Addition to Standard of Care, on the Progression of Kidney Disease in Subjects
Huang, W. (PD/PI), Batlle, D. (Co-Investigator), Wallia, A. (Co-Investigator) & Molitch, M. E. (Other)
Bayer HealthCare Pharmaceuticals, Inc.
1/5/16 → 5/31/20
Project: Research project
-
Urinary Renin Angiotensin System in Diabetes
Batlle, D. (PD/PI), Molitch, M. E. (Co-Investigator), Rademaker, A. W. (Co-Investigator) & Wysocki, J. (Co-Investigator)
National Institute of Diabetes and Digestive and Kidney Diseases
6/15/15 → 4/30/20
Project: Research project
-
Prot #BAY 94-8862/16243: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Assess the Safety and Efficacy of Different Oral Doses of BAY-94-8862 in Subjects with Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropa
Molitch, M. E. (PD/PI), Batlle, D. (Co-PD/PI) & Wallia, A. (Co-PD/PI)
Bayer HealthCare Pharmaceuticals, Inc.
1/2/14 → 1/2/17
Project: Research project
-
PERL: A multicenter clinical trial of allopurinol to prevent GFR loss in T1D
Molitch, M. E. (PD/PI), Batlle, D. (Co-Investigator) & Wallia, A. (Co-Investigator)
Joslin Diabetes Center, Inc., National Institute of Diabetes and Digestive and Kidney Diseases
9/30/13 → 8/31/17
Project: Research project
-
Endothelin and ACE2 Interactions, Implications for Diabetic Kidney Disease
Batlle, D. (PD/PI) & Wysocki, J. (Co-Investigator)
12/13/11 → 6/30/14
Project: Research project
-
Strategies for ACE2 Amplification to Treat Diabetic Kidney Disease
Batlle, D. (PD/PI)
National Institute of Diabetes and Digestive and Kidney Diseases
9/15/09 → 8/31/14
Project: Research project
-
Fellowship in Support of Molecular Regulation of Soluble RAGE and Implications for TID Complications
Batlle, D. (PD/PI)
12/1/08 → 2/28/10
Project: Research project
-
Nocturnal Hypertension in Type 1 Diabetes
Batlle, D. (PD/PI)
10/1/08 → 9/30/13
Project: Research project
-
Fellowship in Support of Melatonin in Type I Diabetics with Nocturnal Hypertension
Batlle, D. (PD/PI)
9/1/08 → 8/31/10
Project: Research project
-
Fellowship in Support of Melatonin in Type I Diabetics with Nocturnal Hypertension
Batlle, D. (PD/PI)
9/1/08 → 8/31/10
Project: Research project
-
Prot# 20070664: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Fixed Dose Study of AMG 223 in Subjects with Chronic Kidney Disease on Hemodialysis with Hyperphosphatemia
Batlle, D. (PD/PI) & Schlueter, W. A. (Co-PD/PI)
Fresenius Medical Care North America, Amgen, Inc.
5/12/08 → 5/12/11
Project: Research project
-
ACE2 as Therapeutic Target for Kidney Disease in Diabetic Mice
Batlle, D. (PD/PI) & Wysocki, J. (Co-Investigator)
12/1/07 → 6/30/11
Project: Research project
-
Nocturnal Hypertension and Prevention of Microalbu
Batlle, D. (PD/PI)
King Pharmaceuticals Research and Development, Inc.
10/30/07 → 10/30/12
Project: Research project
-
Prot# 156-04-251: A Phase 3, Multi-Center, Double-Blind, Placebo-Controlled, Parallel-Arm Trial to Determine Long-Term Safety and Efficacy of Oral Tolvaptan Tablet Regimens in Adult Subjects with Autosomal Dominant Polycystic Kidney Disease
Batlle, D. (PD/PI), Tuazon, J. A. (PD/PI) & Ghossein, C. (Co-PD/PI)
Parexel, Otsuka Maryland Research Institute, Inc.
9/4/07 → 9/4/10
Project: Research project
-
The Effect of Telmisartan on ACE2 in Diabetic Kidney
Batlle, D. (PD/PI)
Boehringer Ingelheim International GmbH
1/1/07 → 1/1/09
Project: Research project
-
The Effect of Telmisartan on ACE2 in Diabetic Kidney
Batlle, D. (PD/PI)
Boehringer Ingelheim International GmbH
1/1/07 → 1/1/09
Project: Research project
-
Prot# 20050182: EVOLVE: Evaluation of Cinacalcet HCI Therapy to Lower CardioVascular Events
Batlle, D. (PD/PI), Tuazon, J. A. (PD/PI) & Schlueter, W. A. (Co-PD/PI)
Fresenius Medical Care North America, Amgen, Inc.
11/3/06 → 5/1/12
Project: Research project
-
Nocturnal Hypertension and Prevention of Microalbuminuria in Type I Diabetics
Batlle, D. (PD/PI), Molitch, M. E. (PD/PI), Molitch, M. E. (Co-PD/PI), Welty, L. J. (Co-PD/PI) & Molitch, M. E. (Co-Investigator)
National Institute of Diabetes and Digestive and Kidney Diseases
9/30/06 → 6/30/13
Project: Research project
-
Medical Education Grant: Center of Excellence in Chronic Kidney Disease (CKD) {Chicago Nephrology Day}
Batlle, D. (PD/PI)
10/19/05 → 10/18/08
Project: Research project
-
Prot# 20040259: A Randomized, Open-Label Study to Assess the Safety of Epoetin Alfa Manufactured by Deep Tank Technology and Epoetin alfa Manufactured by Roller Bottle Technology in Subjects with Chronic Kidney Disease Not on Dialysis
Batlle, D. (PD/PI) & Ghossein, C. (Co-PD/PI)
8/16/05 → 9/10/07
Project: Research project